Masimo & At-Home Continuous Monitoring
Former Strategic Director at GE Healthcare
inpractise.com/articles/masimo-and-at-home-continuous-monitoring
Why is this interview interesting?
- How OEM's integrate Masimo and Nellcor
- Obstacles for hospitals adopting continuous monitoring hardware and software
- A hospital's typical wireless monitoring setup
- How Apple could compete with Masimo in continuous monitoring
Daniel Halstead
Former Strategic Director at GE Healthcare
Daniel has been working within pulse oximetry for the last 40 years. He started in the operating room as an anesthesiologist and saw the transition from non-pulse oximetry to pulse oximetry plus the improvements Masimo’s SET technology had on the industry. He then spent 7 years running Product at Ohmeda, one of the original developers of pulse oximetry, and then spent 14 years at GE Healthcare, which had purchased Ohmeda. Daniel now advises hospitals and OEM’s on at-home monitoring and pulse oximetry.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Related Content
Masimo: Opportunities & Challenges in Telehealth
Former VP of Virtual Care at Healthcare System, Customer of Masimo
Masimo & Hospital and At-Home Patient Monitoring Devices
Director of Virtual Care Operations at St. Luke's University Health Network
Selling Masimo SET & Patient SafetyNet Devices
Former Sales Account Manager at Masimo and Current Territory Manager at Stryker
Surgical Science: Relationship with Intuitive Surgical & Robotic OEM's
Former Customer Learning Manager at Intuitive Surgical
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2023 IP 1 Ltd. All rights reserved.